Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment

Parkinsonism Relat Disord. 2014 Jan;20(1):125-7. doi: 10.1016/j.parkreldis.2013.08.007. Epub 2013 Aug 22.

Authors

Imke Galazky¹, Julia Schoof², Sabine Stallforth², Andreas Kupsch³, Hans-Jochen Heinze², Christian Kluge²

Affiliations

¹ Department of Neurology, Otto-von-Guericke-University, Leipziger Str. 44, D-39120 Magdeburg, Germany. Electronic address: imke.galazky@med.ovgu.de.
² Department of Neurology, Otto-von-Guericke-University, Leipziger Str. 44, D-39120 Magdeburg, Germany.
³ Department of Stereotactic Neurosurgery, Otto-von-Guericke-University, Leipziger Str. 44, D-39120 Magdeburg, Germany.

PMID: 24044946
DOI: 10.1016/j.parkreldis.2013.08.007

No abstract available

Keywords: Demyelinating neuropathy; Guillain Barre Syndrome; Inflammatory neuropathy; Levodopa/carbidopa intestinal gel; Parkinson's disease.

Publication types

Case Reports
Letter

MeSH terms

Aged
Antiparkinson Agents / administration & dosage
Antiparkinson Agents / adverse effects*
Carbidopa / administration & dosage
Carbidopa / adverse effects*
Drug Combinations
Female
Guillain-Barre Syndrome / chemically induced*
Humans
Levodopa / administration & dosage
Levodopa / adverse effects*
Parkinson Disease / drug therapy*
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced*

Substances

Antiparkinson Agents
Drug Combinations
carbidopa, levodopa drug combination
Levodopa
Carbidopa